Search for: "Lupin Pharmaceuticals"
Results 41 - 60
of 175
Sort by Relevance
|
Sort by Date
23 Dec 2012, 11:00 am
In an earlier post (here) we had blogged about the National Pharmaceutical Policy 2011 and its essential features. [read post]
20 Dec 2012, 8:44 am
Lupin Limited, et al., C.A. [read post]
2 Dec 2012, 8:32 pm
• Defendants: Lupin Ltd.; Lupin Pharmaceuticals, Inc. [read post]
21 Nov 2012, 11:32 am
Lupin Ltd., C.A. [read post]
12 Sep 2012, 6:14 pm
Lupin [read post]
12 Sep 2012, 6:08 pm
California -- Johnson & Johnson unit Janssen Pharmaceuticals Inc. was vindicated Tuesday in its efforts to prevent Lupin Pharmaceuticals Inc. from making and marketing a generic version of J&J's popular birth control drug Ortho Tri-Cyclen Lo, as a New Jersey federal judge ruled that the underlying patent is valid. [read post]
12 Sep 2012, 2:41 am
Salix Pharmaceuticals and Dr. [read post]
29 Aug 2012, 7:00 am
Facts of case In Lupin v. [read post]
13 Aug 2012, 1:04 pm
Lupin, the patent owner Shinogi obtained allowance for some but not all of its claims for an extended-release pharmaceutical product. [read post]
3 Aug 2012, 9:51 am
Lupin Ltd. [read post]
30 Jul 2012, 9:55 pm
• Defendants: Lupin Ltd.; Lupin Pharmaceuticals Inc. [read post]
23 May 2012, 9:22 pm
Searle, LLC • Defendants: Lupin Ltd.; Lupin Pharmaceuticals Inc. [read post]
22 Feb 2012, 5:49 pm
Lupin, Ltd. et al. [read post]
3 Jan 2012, 8:15 am
And the fans of Arsène Lupin, the French ‘gentleman burglar’, are now able to borrow – for good! [read post]
17 Nov 2011, 2:17 am
The winners were as follows: Copyright law firm of the year: Berwin Leighton Paisner Trade mark law firm of the year: Grau & Angulo Patent law firm of the year: Allen & Overy IP law firm of the year in an emerging market: Remfry & Sagar IP Law firm of the year: Allen & Overy Domain name/online strategy of the year: Kilpatrick Townsend & Stockton for the Namealizer, a domain name evaluation tool Outstanding IP portfolio management/development in… [read post]
7 Sep 2011, 4:22 am
Apotex (Patently-O) Glivec (Imatinib mesylate) – India: The Glivec patent saga – its raining recusals (Spicy IP) Glivec (Imatinib mesylate) – India: Supreme Court to hear Novartis challenge to India’s patent law (IP Watch) Lo Loestrin Fe (Norethindrone acetate / Ethinyl estradiol / Ferrous fumarate) – US: Warner Chilcott files patent infringement complaint against Lupin in response to Para IV certification (Patent Docs) Lumigan (Bimatoprost) – US:… [read post]
10 Aug 2011, 4:30 am
Lupin Ltd. et al. [read post]
3 Aug 2011, 3:31 am
Patent and Trademark Office (Holman’s Biotech IP Blog) US: Myriad writes to CAFC on standing issue (Patent Docs) (Patent Docs) (Holman’s Biotech IP Blog) US: In the first 7 months of 2011, the FDA has approved 18 new molecular entity pharmaceutical drugs (and no biologic NMEs) (KEI) US: Embryonic stem cell funding suit dead: Sherley v. [read post]
27 Jul 2011, 1:01 am
KG (TTABlog) US: ALJ Rogers sets 17-month target date in Certain Coenzyme Q10 Products (337-TA-790) (ITC 337 Law Blog) Products Alimta (Pemetrexed) – US: Eli Lilly files patent infringement complaints against APP Pharmaceuticals in Delaware and S D Indiana in response to Para IV certification filing (Patent Docs) Cenestin (Synthetic conjugated estrogens) – US: CAFC: Prosecution history estoppel bars Duramed’s allegations of infringement under doctrine of… [read post]
18 Jul 2011, 8:21 am
Lupin, Sanofi v. [read post]
